Exactly MRNA has had superb cancer news. Hell I would say a 90% reduction in tumors is freaking huge. The CEO already stated that they are looking to sign atleast one major pharma deal over here and one over seas by the end of the year. They stated that they also had many on going conversations with some overseas pharma's. The CEO stated that he was very confident he would meet that 50 million market cap that the nasdaq needs. That equals atleast 1.30 a share. The financing they just did had 5 million warrants for 2.00 and 2.39 for the other 5 million. So its trading way under the warrants. The CEO has already signed a deal with Roche. He signed a deal with Par Pharmaceutical that got them royalties on their FDA approved osteoporosis drug and they have no out of pocket expense at all. He also signed a Development and License Agreement with Amylin Pharmaceuticals, Inc. for the development of intranasal exenatide. Under terms of the amended agreement, Amylin has committed to advancing the program, resulting in an accelerated $1 million milestone payment to MDRNA. Further, under terms of the amended agreement, MDRNA could receive an additional $79 million in future milestones and royalties. He Payed GE capital in full and eliminated the debt with them and by doing so they got 100% owership of their technology. Last go back and look at the management team they have put together. They had landed some very nice talent in the field. The bottom line this one is going to explode soon enough.
AI
